A one-time $2.2 million investment from the State of California under Assembly Bill 2664 is propelling new and expanded innovation and entrepreneurship initiative at the University of California, Davis, through enhancements related to infrastructure, resources, and business training programs. 

The programs represent a coordinated and collaborative effort among several campus entities including the Office of Research, Institute for Innovation and Entrepreneurship, Student Startup Center, Biomedical Engineering, Office of the Provost, Office of Graduate Studies, and Internship and Career Center.



Approximately two years into the initiative, new and expanded programs have directly enabled 19 startups, accelerated 47 companies, led to 37 products, delivered 1,900 hours of mentoring, and trained over 950 aspiring entrepreneurs.

Featuring:

The SBIR/STTR Program, also known as “America’s Seed Fund”, provides nearly $3 billion in funding each year to support the development of innovative technologies. This workshop will cover all aspects of how to strategically approach obtaining funding from the SBIR/STTR Program. Topics will include aligning your business and technology development needs with available SBIR/STTR opportunities, proposal development, budgets, and award management. The workshop will be led by Dr. Eva Garland and Dr. Angela Pollard, who have over 20 years of experience successfully securing hundreds of millions of dollars in SBIR/STTR funding for their own companies as well as for clients. Members of the Venture Catalyst team will also be available to engage with UC Davis affiliated startups interested in pursuing an SBIR/STTR grant.

WHEN:

Tuesday, October 16, 2018, 5:30PM - 8PM

WHERE:

Join us for Dinner @

UC Davis Office of Research

1850 Research Park Drive

Davis, CA 95618

Featuring:

This talk will provide insights on developing therapeutics, including strategies to advance the timeline to get to the clinic, out-license, or spin out a company. Dr. Templin will discuss what the NIH is looking for in funding submission for early discovery packages related to compounds and target engagement as well as what the FDA and other regulatory bodies are looking for in an IND submission for preclinical development.

UC Davis startups and Venture Catalyst START Program participants interested in having a one-on-one meeting with Charles River representatives following the talk to discuss contract research for an SBIR/STTR proposal submission or other company R&D needs, please click here to select an available 30-minute slot.

WHEN:

Tuesday, September 25, 2018, 11:30AM - 1:00PM

WHERE:

Join us for Lunch @

Oak Park Research Building, UC Davis Health Campus

2700 Stockton Blvd, Seminar Room 1305

Sacramento, CA 95817

The Innovation Institute for Food and Health (IIFH), in collaboration with Venture Catalyst, is partnering with FoodShot Global, a world-class consortium of investors, universities, and foundations to accelerate food system transformation through “Moonshots for Better Food”. Together, IIFH and the FoodShot consortium are expanding a vibrant innovation community in food and health, focusing on soil in their first annual challenge: Innovating Soil 3.0, which seeks projects and ideas that utilize the latest in technology, science and engineering to address the crisis of soil deterioration.... Read More

A multidisciplinary team from UC Davis, University of Wisconsin–Madison, and Mars, Incorporated have found an indigenous variety of corn that can “fix nitrogen” from the atmosphere, instead of requiring synthetic fertilizers for enhanced growth. The team’s findings were published in the journal PLOS Biology. If this trait can be bred into conventional varieties of corn, it could reduce the need for added fertilizer and increase yields in regions with poor soil. Corn that fixes nitrogen could also help farmers in developing countries, who may not have access to fertilizer.... Read More

UC Davis department of biomedical engineering researchers created "Lego block” artificial cells that can kill bacteria. The team’s artificial cells mimic the essential features of live cells, but are short-lived and cannot divide to reproduce themselves. The cells were designed to respond to a unique chemical signature on E. coli bacteria. They were able to detect, attack and destroy the bacteria in laboratory experiments. Antibacterial artificial cells can one day be infused into patients to tackle infections resistant to other treatments. They can also be used to deliver drugs at the specific location and time, or as biosensors.... Read More

Nine teams, including UC Davis stem cell researchers, are pursuing a cure for a rare disorder with links to autism, Alzheimer's disease, and cancer. The condition, known as Jordan’s syndrome, is named after Jordan Lang, the first child diagnosed in the U.S. Through Jordan’s Guardian Angels foundation, an international team of clinicians and scientists have been collaborating on research since 2017 to learn about the mutation, which caused Jordan’s neurodevelopmental disorder. In June 2018 California Governor Jerry Brown signed the 2018-19 state budget, which included a one-time $12 million appropriation for Jordan’s syndrome research. UC Davis Health became involved in Jordan syndrome research in March 2017, after Jordan Lang’s pediatric neurologist heard an aneurology grand rounds talk describing the work at the Institute for Regenerative Cures. According to Jan Nolta, director of the UC Davis Institute for Regenerative Cures, state funding is especially important with the lack of federal funding for large program project grants.... Read More

UC Davis was recently recognized as a top-ranked university by several different publications, including:

In addition, U.S. News ranks the UC Davis Medical Center among the nation's best in 11 specialties; number 5 in California, and first in Sacramento.

UC’s Office of Innovation and Entrepreneurship (I&E) has established a liaison office in Beijing at TusStar, a leading tech incubator and early-stage investment fund. The key objective of this liaison office is to provide business development and business-matching services as well as overall administrative support to UC startups looking to expand their business in China. The new UC office will be located inside TusPark, the largest science park in Zhongguancun, the “Silicon Valley hub” of Beijing where multinational tech companies, such as Google, are based.... Read More

About Venture Catalyst 

 

UC Davis Venture Catalyst facilitates the translation of University research and technology by enabling the development of new ventures. Venture Catalyst engages with the Davis and Sacramento business, governmental and economic development community to highlight the development of technologies and ventures coming out of UC Davis that will drive tomorrow’s regional job creation. Working closely with these partners, Venture Catalyst is invigorating the technology-based entrepreneurial ecosystem of the entire region. 

The Venture Catalyst START™ Suite of programs and services provides the ABCs to equip UC Davis entrepreneurs with the tools they need to form and grow robust startups. The program gives founders the START they need to create a well-structured company and ensure the company is prepared for success. 

 

Contact Venture Catalyst 

For more information or for editorial comments, please email us .